Formosa Pharmaceuticals and Saval Corporation announces the license agreement for the CloTasol ProPionate Suspension for the treatment of inflammation and pain after the surgery

Photo of author

By [email protected]




Formosa Pharmaceuticals and Saval Corporation announces the license agreement for the CloTasol ProPionate Suspension for the treatment of inflammation and pain after the surgery



[og_img]

Source link

Leave a Comment